한글목차

세계의 메조테라피 시장 규모는 예측 기간 중 CAGR로 12.48%의 대폭적인 성장이 예측됩니다.

지역 인사이트

북미는 2022년에 36.31%의 최대 시장 점유율을 차지했습니다. 이것은 메조테라피와 같은 교정 방법의 높은 보급률과 무수한 수복 전문가의 존재에 기인합니다.

유럽은 다수의 환자 및 세련된 외모에 대한 관심의 향상, 주요 조직의 존재에 의해 추산 기간 중 중대한 발전을 보일 전망입니다. 독일 시장이 2022년에 최대 시장 점유율을 차지하며, 유럽에서 가장 급속히 발전하고 있습니다.

아시아태평양은 예측 기간 중 가장 현저한 성장률을 보일 전망입니다. 이것은 의료 서비스 기반의 더 큰 발전 등의 요인에 의한 것입니다.

세계의 메조테라피 시장에 대해 조사분석했으며, 시장 역학, 지역과 부문 분석, 기업 개요 등을 제공하고 있습니다.

목차

제1장 주요 요약

제2장 시장의 서론

제3장 조사 방법

제4장 시장 역학

• 서론
• 촉진요인
  • 피부 질환과 탈모의 만연
  • 의료관광의 채택 확대
  • 촉진요인의 영향 분석
• 억제요인
  • 치료에 수반하는 부작용
  • 억제요인의 영향 분석
• 기회
  • 라이프스타일의 변화와 도시화의 진행

제5장 시장 요인 분석

• 밸류체인 분석
  • 연구개발
  • 제조
  • 유통, 판매
  • 판매 후 모니터링
• Porter's Five Forces 모델
• 세계의 메조테라피 시장에 대한 COVID-19의 영향
  • 공급망에 대한 영향
  • 지역에 대한 영향
  • 프로바이더에 대한 영향

제6장 세계의 메조테라피 시장 : 제품별

• 개요
• 메조테라피 솔루션
• 메조테라피 마스크
• 메조테라피 크림
• 메조테라피 디바이스
• 기타

제7장 세계의 메조테라피 시장 : 용도별

• 개요
• 안티에이징
• 안면 회춘
• 튼살
• 여드름과 흉터 치료
• 지방 감소
• 탈모
• 기타

제8장 세계의 메조테라피 시장 : 최종사용자별

• 개요
• 병원
• 피부과 클리닉
• 기타

제9장 세계의 메조테라피 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타 유럽
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 한국
  • 호주
  • 기타 아시아태평양
• 기타 지역
  • 중동
  • 아프리카
  • 라틴아메리카

제10장 경쟁 구도

• 개요
• 경쟁 벤치마킹
• 세계의 메조테라피 시장에서의 주요 성장 전략
• 세계의 메조테라피 시장에서 개발수에서의 주요 기업
• 주요 발전과 성장 전략
  • 제품 승인과 발매

제11장 기업 개요

• FILORGA
• MESOSKINLINE
• KORU PHARMACEUTICALS CO., LTD.
• FUSION MESO
• TOSKANI COSMETICS
• ABBVIE INC.
• GALDERMA LABORATORIES, L.P
• DERMOAROMA
• MESSOESSENCE
• INSTITUTE BCN

제12장 부록

영문목차

Market Overview

Mesotherapy Market is projected to register a significant CAGR of 12.48% during the forecast period.

The variables adding to the development of the market are the rising predominance of skin issues and going bald and the developing reception of clinical the travel industry.

Mesotherapy is a method that utilizes infusions of chemicals, nutrients, proteins, and plant concentrates to lessen the overabundance of fat and revive the skin. Skin issues, for example, skin inflammation turn out to be more normal due to heredity, meds, smoking, and nicotine.

Furthermore, many non-industrial countries have as of late fabricated state-of-the-art clinical offices and given medical care administrations for a portion of the cost of created countries. Perhaps of the most well-known method in the clinical, the travel industry area is a restorative medical procedure. Most superficial medical procedures are self-financed, so this area of the worldwide clinical travel industry market has become progressively determined by the surface level a medical procedure. Clinical travel industry areas have a sizable number of corrective medical procedure offices. Subsequently, rising rates of balding and skin issues and the developing reception of clinical the travel industry is moving the market development.

Market Segmentation

The Mesotherapy Market has been divided into various product categories, including mesotherapy solutions, masks, lotions, gadgets, and others.

Based on application the market is divided into fat loss, hair loss, stretch marks, anti-aging, face rejuvenation, acne & scar treatment, and others. The Mesotherapy Market has been divided into hospitals, dermatological clinics, and other entities based on end users.

Regional Insights

North America represented the biggest market portion of 36.31% in 2022 attributable to the high ubiquity of corrective methodology, for example, mesotherapy and the presence of countless restorative specialists in the region. According to the Global Society of Tasteful Plastic Medical procedure (ISAPS), in 2020, there were about more than 7,000 rehearsing plastic specialists in the US.

Europe is expected to observe critical development during the estimated time frame because of a bigger number of patients, the rising concern in regard to tasteful appearance, and the presence of key organizations in the region. According to the Worldwide Society of Tasteful Plastic Medical Procedure (ISAPS), Germany, and Italy represented the most elevated non-surgeries in the region in 2020. Moreover, the Germany mesotherapy market held the biggest market share in 2022 and is the quickest-developing market in the Europe region.

Asia-Pacific is expected to enroll the most noteworthy development rate over the conjecture period. This is because of variables like further developing medical services foundation, developing venture by key part with neighborhood producers, expanding restorative uses, and developing interest for tasteful techniques inside the region.

Major Players

Key Companies in the Mesotherapy Market include FILORGA (France), Koru Pharmaceuticals Co., LTD. (South Korea), Fusion Meso (Spain), Mesoskinline (Denmark), Toskani Cosmetics (Spain), AbbVie Inc. (US), Dermoaroma (Italy), Galderma Laboratories, L.P. (Switzerland), Messoessence (Spain), and Institute BCN (Spain).

TABLE OF CONTENTS

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

• 2.1 DEFINITION
• 2.2 SCOPE OF THE STUDY
• 2.3 RESEARCH OBJECTIVE
• 2.4 LIST OF ASSUMPTIONS & LIMITATIONS

3 RESEARCH METHODOLOGY

• 3.1 DATA MINING
• 3.2 SECONDARY RESEARCH
• 3.3 PRIMARY RESEARCH
  • 3.3.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • 3.3.2 BREAKDOWN OF PRIMARY RESPONDENTS
• 3.4 FORECASTING TECHNIQUES
• 3.5 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
  • 3.5.1 BOTTOM-UP APPROACH
  • 3.5.2 TOP-DOWN APPROACH
• 3.6 DATA TRIANGULATION
• 3.7 VALIDATION

4 MARKET DYNAMICS

• 4.1 INTRODUCTION
• 4.2 DRIVERS
  • 4.2.1 INCREASING PREVELANCE OF SKIN PROBLEMS AND HAIR LOSS
  • 4.2.2 GROWING ADOPTION OF MEDICAL TOURISM
  • 4.2.3 DRIVERS IMPACT ANALYSIS
• 4.3 RESTRAINTS
  • 4.3.1 SIDE EFFECTS ASSOCIATED WITH THE THERAPY
  • 4.3.2 RESTRAINTS IMPACT ANALYSIS
• 4.4 OPPORTUNITIES
  • 4.4.1 CHANGING LIFESTYLE AND INCREASING URBANIZATION

5 MARKET FACTOR ANALYSIS

• 5.1 VALUE CHAIN ANALYSIS
  • 5.1.1 R&D
  • 5.1.2 MANUFACTURING
  • 5.1.3 DISTRIBUTION & SALES
  • 5.1.4 POST-SALES MONITORING
• 5.2 PORTER'S FIVE FORCES MODEL
  • 5.2.1 THREAT OF NEW ENTRANTS
  • 5.2.2 BARGAINING POWER OF SUPPLIERS
  • 5.2.3 THREAT OF SUBSTITUTES
  • 5.2.4 BARGAINING POWER OF BUYERS
  • 5.2.5 INTENSITY OF RIVALRY
• 5.3 IMPACT OF COVID-19 ON THE GLOBAL MESOTHERAPY MARKET
  • 5.3.1 IMPACT ON SUPPLY CHAIN
  • 5.3.2 IMPACT ON REGIONS
  • 5.3.3 IMPACT ON PROVIDERS

6 GLOBAL MESOTHERAPY MARKET, BY PRODUCT

• 6.1 OVERVIEW
• 6.2 MESOTHERAPY SOLUTIONS
• 6.3 MESOTHERAPY MASKS
• 6.4 MESOTHERAPY CREAMS
• 6.5 MESOTHERAPY DEVICES
• 6.6 OTHERS

7 GLOBAL MESOTHERAPY MARKET, BY APPLICATION

• 7.1 OVERVIEW
• 7.2 ANTI-AGING
• 7.3 FACIAL REJUVENATION
• 7.4 STRETCH MARKS
• 7.5 ACNE & SCAR TREATMENT
• 7.6 FAT LOSS
• 7.7 HAIR LOSS
• 7.8 OTHERS

8 GLOBAL MESOTHERAPY MARKET, BY END USER

• 8.1 OVERVIEW
• 8.2 HOSPITALS
• 8.3 DERMATOLOGY CLINICS
• 8.4 OTHERS

9 GLOBAL MESOTHERAPY MARKET, BY REGION

• 9.1 OVERVIEW
• 9.2 NORTH AMERICA
  • 9.2.1 US
  • 9.2.2 CANADA
• 9.3 EUROPE
  • 9.3.1 GERMANY
  • 9.3.2 FRANCE
  • 9.3.3 UK
  • 9.3.4 ITALY
  • 9.3.5 SPAIN
  • 9.3.6 REST OF EUROPE
• 9.4 ASIA-PACIFIC
  • 9.4.1 CHINA
  • 9.4.2 JAPAN
  • 9.4.3 INDIA
  • 9.4.4 SOUTH KOREA
  • 9.4.5 AUSTRALIA
  • 9.4.6 REST OF ASIA-PACIFIC
• 9.5 REST OF THE WORLD
  • 9.5.1 MIDDLE EAST
  • 9.5.2 AFRICA
  • 9.5.3 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

• 10.1 OVERVIEW
• 10.2 COMPETITIVE BENCHMARKING
• 10.3 MAJOR GROWTH STRATEGY IN THE GLOBAL MESOTHERAPY MARKET
• 10.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE GLOBAL MESOTHERAPY MARKET
• 10.5 KEY DEVELOPMENTS & GROWTH STRATEGIES
  • 10.5.1 PRODUCT APPROVAL AND LAUNCH

11 COMPANY PROFILE

• 11.1 FILORGA
  • 11.1.1 COMPANY OVERVIEW
  • 11.1.2 FINANCIAL OVERVIEW
  • 11.1.3 PRODUCTS OFFERED
  • 11.1.4 KEY DEVELOPMENTS
  • 11.1.5 SWOT ANALYSIS
  • 11.1.6 KEY STRATEGIES
• 11.2 MESOSKINLINE
  • 11.2.1 COMPANY OVERVIEW
  • 11.2.2 FINANCIAL OVERVIEW
  • 11.2.3 PRODUCTS OFFERED
  • 11.2.4 KEY DEVELOPMENTS
  • 11.2.5 KEY STRATEGIES
• 11.3 KORU PHARMACEUTICALS CO., LTD.
  • 11.3.1 COMPANY OVERVIEW
  • 11.3.2 FINANCIAL OVERVIEW
  • 11.3.3 PRODUCTS OFFERED
  • 11.3.4 KEY DEVELOPMENTS
  • 11.3.5 KEY STRATEGIES
• 11.4 FUSION MESO
  • 11.4.1 COMPANY OVERVIEW
  • 11.4.2 FINANCIAL OVERVIEW
  • 11.4.3 PRODUCTS OFFERED
  • 11.4.4 KEY DEVELOPMENTS
  • 11.4.5 SWOT ANALYSIS
  • 11.4.6 KEY STRATEGIES
• 11.5 TOSKANI COSMETICS
  • 11.5.1 COMPANY OVERVIEWS
  • 11.5.2 FINANCIAL OVERVIEW
  • 11.5.3 PRODUCTS OFFERED
  • 11.5.4 KEY DEVELOPMENTS
  • 11.5.5 KEY STRATEGIES
• 11.6 ABBVIE INC.
  • 11.6.1 COMPANY OVERVIEW
  • 11.6.2 FINANCIAL OVERVIEW
  • 11.6.3 PRODUCTS OFFERED
  • 11.6.4 ABBVIE INC.: KEY DEVELOPMENTS
  • 11.6.5 SWOT ANALYSIS
  • 11.6.6 KEY STRATEGIES
• 11.7 GALDERMA LABORATORIES, L.P
  • 11.7.1 COMPANY OVERVIEW
  • 11.7.2 FINANCIAL OVERVIEW
  • 11.7.3 PRODUCTS OFFERED
  • 11.7.4 KEY DEVELOPMENTS
  • 11.7.5 SWOT ANALYSIS
  • 11.7.6 KEY STRATEGIES
• 11.8 DERMOAROMA
  • 11.8.1 COMPANY OVERVIEW
  • 11.8.2 FINANCIAL OVERVIEW
  • 11.8.3 PRODUCTS OFFERED
  • 11.8.4 KEY DEVELOPMENTS
  • 11.8.5 SWOT ANALYSIS
  • 11.8.6 KEY STRATEGIES
• 11.9 MESSOESSENCE
  • 11.9.1 COMPANY OVERVIEW
  • 11.9.2 FINANCIAL OVERVIEW
  • 11.9.3 PRODUCTS OFFERED
  • 11.9.4 KEY DEVELOPMENTS
  • 11.9.5 KEY STRATEGIES
• 11.10 INSTITUTE BCN
  • 11.10.1 COMPANY OVERVIEW
  • 11.10.2 FINANCIAL OVERVIEW
  • 11.10.3 PRODUCTS OFFERED
  • 11.10.4 KEY DEVELOPMENTS
  • 11.10.5 KEY STRATEGIES

12 APPENDIX

• 12.1 REFERENCES
• 12.2 RELATED REPORTS